Kei Takuma

Albumin–bilirubin score indicates liver fibrosis staging and prognosis in patients with chronic hepatitis C

Koji Fujita, Kyoko Oura, Hirohito Yoneyama et al. · Hepatology Research · 2019 · 66 citations · Full text

Medicine, Internal Medicine, Pathology +17

Simple scoring system for prediction of hepatocellular carcinoma occurrence after hepatitis C virus eradication by direct‑acting antiviral treatment: All Kagawa Liver Disease Group Study

Joji Tani, Asahiro Morishita, Teppei Sakamoto et al. · Oncology Letters · 2020 · 55 citations · Full text

Medicine, Infectious Diseases, Oncology +16

Evaluating the Effect of Lenvatinib on Sorafenib-Resistant Hepatocellular Carcinoma Cells

Tingting Shi, Hisakazu Iwama, Koji Fujita et al. · International Journal of Molecular Sciences · 2021 · 32 citations · Full text

Medicine, Oncology, Pharmacology +13

Pemafibrate improves liver dysfunction and non-invasive surrogates for liver fibrosis in patients with non-alcoholic fatty liver disease with hypertriglyceridemia: a multicenter study

Asahiro Morishita, Kyoko Oura, Kei Takuma et al. · Hepatology International · 2022 · 30 citations · Full text

Medicine, Pharmacotherapy, Clinical Nutrition +16

Aspirin inhibits hepatocellular carcinoma cell proliferation in vitro and in vivo via inducing cell cycle arrest and apoptosis

Tingting Shi, Koji Fujita, Jian Gong et al. · Oncology Reports · 2020 · 29 citations · Full text

Medicine, Oncology, Pharmacology +16